185 related articles for article (PubMed ID: 36246623)
1. Integrative analyses of prognosis, tumor immunity, and ceRNA network of the ferroptosis-associated gene FANCD2 in hepatocellular carcinoma.
Yang Z; Song Y; Li Y; Mao Y; Du G; Tan B; Zhang H
Front Genet; 2022; 13():955225. PubMed ID: 36246623
[TBL] [Abstract][Full Text] [Related]
2. FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma.
Tang X; Luo B; Huang S; Jiang J; Chen Y; Ren W; Shi X; Zhang W; Shi L; Zhong X; Lü M
Eur J Med Res; 2023 Oct; 28(1):419. PubMed ID: 37821996
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG1 upregulates FANCD2 and G6PD to suppress ferroptosis by sponging miR-199a-5p/3p in hepatocellular carcinoma.
Zhou L; Zhang Q; Cheng J; Shen X; Li J; Chen M; Zhou C; Zhou J
Drug Discov Ther; 2023 Sep; 17(4):248-256. PubMed ID: 37599085
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Ferroptosis-Related Fanconi Anemia Group D2 is a Poor Prognostic Factor and an Indicator of Tumor Immune Cell Infiltration in Lung Adenocarcinoma.
Zhang J; Wang D; Chen X; Ji L; Yu M; Guo M; Zhang D; Chen W; Xu F
Front Genet; 2022; 13():825685. PubMed ID: 35646059
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma.
Zhang L; Hu S; Chen J; Ma S; Liu F; Liu C; Gao Y
Discov Oncol; 2021 Oct; 12(1):38. PubMed ID: 35201491
[TBL] [Abstract][Full Text] [Related]
6. Identification of the ferroptosis-related prognostic gene signature in mesothelioma.
Wang Z; Huang J; MinYang ; Fu L; Liu S; Huang J; Han J; Zhao X
Gene; 2024 Aug; 919():148498. PubMed ID: 38670397
[TBL] [Abstract][Full Text] [Related]
7. Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma.
Song L; Wu J; Fu H; Wu C; Tong X; Zhang M
Front Pharmacol; 2022; 13():921963. PubMed ID: 35754466
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.
Miao H; Ren Q; Li H; Zeng M; Chen D; Xu C; Chen Y; Wen Z
BMC Cancer; 2022 Mar; 22(1):225. PubMed ID: 35236309
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of
Komatsu H; Masuda T; Iguchi T; Nambara S; Sato K; Hu Q; Hirata H; Ito S; Eguchi H; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Anticancer Res; 2017 Mar; 37(3):1083-1090. PubMed ID: 28314268
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
Front Genet; 2021; 12():682082. PubMed ID: 34745200
[No Abstract] [Full Text] [Related]
11. ncRNAs-mediated overexpression of STIL predict unfavorable prognosis and correlated with the efficacy of immunotherapy of hepatocellular carcinoma.
Xu L; Zhang S; Feng J; Tan D; Sun H; Guo H
Cancer Cell Int; 2023 Mar; 23(1):44. PubMed ID: 36899391
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma.
Zhu D; Wu S; Li Y; Zhang Y; Chen J; Ma J; Cao L; Lyu Z; Hou T
Cancer Cell Int; 2022 Mar; 22(1):124. PubMed ID: 35305616
[TBL] [Abstract][Full Text] [Related]
13. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
14. A ferroptosis-related ceRNA network in hepatocellular carcinoma for potential clinical applications.
Yang Z; He K; Chen W; Chen Y
Am J Transl Res; 2023; 15(6):3912-3927. PubMed ID: 37434825
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma.
Shi Y; Zhang DD; Liu JB; Yang XL; Xin R; Jia CY; Wang HM; Lu GX; Wang PY; Liu Y; Li ZJ; Deng J; Lin QL; Ma L; Feng SS; Chen XQ; Zheng XM; Zhou YF; Hu YJ; Yin HQ; Tian LL; Gu LP; Lv ZW; Yu F; Li W; Ma YS; Da F
Mol Ther Nucleic Acids; 2021 Mar; 23():702-718. PubMed ID: 33575116
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
Front Genet; 2022; 13():907331. PubMed ID: 35938001
[No Abstract] [Full Text] [Related]
17. Role of ferroptosis and its non-coding RNA regulation in hepatocellular carcinoma.
Yang L; Guan Y; Liu Z
Front Pharmacol; 2023; 14():1177405. PubMed ID: 37124203
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of ceRNA network reveals potential prognostic Hint1-related lncRNAs involved in hepatocellular carcinoma progression.
Zhang C; Bao T; Ke Y; Liu X; Wang X; Liao W; He Y; Wang L
World J Surg Oncol; 2022 Mar; 20(1):67. PubMed ID: 35241097
[TBL] [Abstract][Full Text] [Related]
19. Systematic Analysis and Validation of the Prognosis, Immunological Role and Biology Function of the Ferroptosis-Related lncRNA GSEC/miRNA-101-3p/CISD1 Axis in Lung Adenocarcinoma.
Jiang X; Yuan Y; Tang L; Wang J; Zhang D; Duan L
Front Mol Biosci; 2021; 8():793732. PubMed ID: 35320929
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma.
Chen R; Chen Y; Huang W; Zhao Y; Luo W; Lin J; Wang Z; Yang J
Aging (Albany NY); 2021 Jul; 13(13):17607-17628. PubMed ID: 34237706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]